Research@UIC > Life Sciences Initiative > Announcement

Announcement

Catalyzing Collaboration
Between
Industry and Academia in the Life Sciences

Call for Participation - Friday, November 14th, 2008

Topic: Diabetes Mellitus: Diagnosis, Treatment and Complications

Date:              

Friday, November 14th, 2008 - Agenda

Location:       

Rosalind Franklin University of Medicine and Science
3333 Green Bay Road
North Chicago, IL 60064

Become part of an on-going forum to bring life science researchers from universities and business together to exchange ideas, discuss challenges, and explore potential collaborations to promote commercialization. At this forum, you will address problems that need solving and explore opportunities to move research from the bench to the bedside and for the greater public good.

This forum is the seventh in a series of collaborations between Midwest area universities and biotech/healthcare/pharmaceutical firms. The forum provides a unique combination of presentations, roundtable discussions, and networking.

Meet and network with people from all areas of the life sciences!

Register for this Forum via this link:

www.research.uic.edu/air/registration

(Cut and paste link to site if not connected automatically)

Invited Companies

Abbott, Baxter, Takeda, TAP, Eli Lilly and Co., Ovation Pharmaceuticals,
Merck, Pfizer and Advanced Life Sciences

RESERVE EARLY; LIMITED SEATING!!!!!

Abstract / Poster Submission:

Faculty members actively conducting research as it relates to Diabetes Mellitus: Diagnosis, Treatment and complications are invited to submit a poster and/or abstract (in 250 words or less) in at least one of the following areas for review:

• Clinical Diagnostic or Therapeutic Applications,
• New Research Methodologies or,
• Platform Technologies.
  

Submission website: 

http://tigger.uic.edu/depts/ovcr/research/air/submission.html

Presentation selection will be based upon the following Criteria: 
Research topic stage of development -- 20% 
Potential to discover/develop critical medical outcomes through research topic -- 40% 
Potential commercial impact of research topic -- 40% 

Please contact Michael Sarras, Ph. D., VP of Research, Rosalind Franklin University of Medicine and Science at Michael.Sarras@rosalindfranklin.edu or (847) 578-3251 with questions.